about
Nurse-led telecoaching of people with type 2 diabetes in primary care: rationale, design and baseline data of a randomized controlled trialBelgian primary care EPR: assessment of nationwide routine data extraction.Patient and provider acceptance of telecoaching in type 2 diabetes: a mixed-method study embedded in a randomised clinical trial.Diversity in diabetes care programmes and views on high quality diabetes care: are we in need of a standardized framework?Interdisciplinary diabetes care teams operating on the interface between primary and specialty care are associated with improved outcomes of care: findings from the Leuven Diabetes Project.The Intego database: background, methods and basic results of a Flemish general practice-based continuous morbidity registration projectWhat determines inclusion in the early phase of the type 2 diabetes care trajectory in Belgium?Quality assessment of automatically extracted data from GPs' EPR.Relevance of chronic lyme disease to family medicine as a complex multidimensional chronic disease construct: a systematic reviewThe correlation between blood pressure and kidney function decline in older people: a registry-based cohort study.Does the Belgian diabetes type 2 care trajectory improve quality of care for diabetes patients?Cardiovascular prevention in type 2 diabetic patients: review of efficacious treatments.Delivering Diabetes Education through Nurse-Led Telecoaching. Cost-Effectiveness Analysis.A cluster randomized trial to improve adherence to evidence-based guidelines on diabetes and reduce clinical inertia in primary care physicians in Belgium: study protocol [NTR 1369].Barriers and facilitators to evidence based care of type 2 diabetes patients: experiences of general practitioners participating to a quality improvement programLong-term evolution of renal function in patients with type 2 diabetes mellitus: a registry-based retrospective cohort study.Antibiotic prescribing in relation to diagnoses and consultation rates in Belgium, the Netherlands and Sweden: use of European quality indicators.Factors associated with Prolonged Inaction in the hypoglycaemic treatment in people with non-insulin dependent Type 2 Diabetes and elevated glycated haemoglobin: A registry-based cohort study.Prescription of Antibiotics to Treat Gonorrhoea in General Practice in Flanders 2009-2013: A Registry-Based Retrospective Cohort Study.Public Health Triangulation to inform decision-making in Belgium.Start improving the quality of care for people with type 2 diabetes through a general practice support program: a cluster randomized trial.EPR-based, quality-related process parameters: a nationwide assessment.Type 2 diabetes in primary care in belgium: need for structured shared care.Estimating the prevalence of diabetes mellitus and thyroid disorders using medication data in Flanders, Belgium.Optimizing diabetes control in people with Type 2 diabetes through nurse-led telecoaching.Cardiovascular prevention in general practice: development and validation of an algorithm.Health problems associated with irritable bowel syndrome: analysis of a primary care registry.Designing a Patient Portal for Patient-Centered Care: Cross-Sectional SurveyTime trends in statin use and incidence of recurrent cardiovascular events in secondary prevention between 1999 and 2013: a registry-based studyIs there a correlation between an eGFR slope measured over a 5-year period and incident cardiovascular events in the following 5 years among a Flemish general practice population: a retrospective cohort studyHealth Data for Research Through a Nationwide Privacy-Proof System in Belgium: Design and Implementation.Statins in patients at high risk of cardiovascular disease presenting with peripheral artery diseaseNation-wide primary healthcare research network: a privacy protection assessment
P50
Q30748190-048FCB7D-B202-487E-A97A-5251678DE083Q30803228-C802C826-8CA9-4B37-914E-566813ABC976Q30828070-ED82D01D-3C92-4B8C-A1B0-D89229896B30Q33336554-42641A06-9D40-40E3-9090-9DA2A0B56E39Q33509162-1017885F-B45C-48F1-B7E4-87DA157A2212Q33794848-B220CB43-2AB3-4BAE-816E-2C0B4612E655Q34196933-49E3CDD8-9533-48C8-A116-7A80456DA11DQ34371695-BEE65DD8-4CC7-4D86-96F5-5D9302F8EC0DQ34650391-38F6D2A0-EB22-4548-B296-EF86F0B76DEFQ35803257-5D75BE9E-7792-4E5A-88EF-EEEB6FB8052CQ35844852-53154F22-A7C1-4F70-98EB-F9004EB5AFE5Q36093161-2404A2B2-B2A1-4755-B6FB-D7F62AFAF672Q36160381-2C0A5659-6BC9-4002-822A-76422090B08CQ36942639-7BE237CF-02C9-4A71-88F6-5B6859E3E8BAQ37285724-1031B9BA-507F-4367-A195-EBCDF5D55965Q37449259-971C76EA-3273-42EF-B8B6-99E341099CBAQ37715164-7FA5C2BD-FC50-49BD-9A19-FF477ED1648FQ38709728-E0AD1849-7446-46F9-BE1B-5996DE8486E5Q40074503-677A1517-0CBA-4624-B4D0-88636639DBA6Q40921648-2725DA9A-689E-4E47-9E1F-7FE89EF7D78EQ43202757-A9DE4883-E463-4C82-B9D1-99D17E586E57Q44561959-C704D321-BF2A-4A09-876A-674808B203C6Q46055558-3BB2AECE-30B6-4F01-922D-4BF06E213826Q47827434-91AD34F3-20EF-47F0-A065-2CC368C4DE33Q49072938-FFDF232C-43E4-4BC8-8D4B-1AF00837AF3CQ51980838-97590B19-DAA6-4269-8A74-86ED9204A2D6Q54249473-4726F755-9958-4B22-90F9-1830A16EEDB6Q57057709-F462C727-1AC1-4756-AE07-004ED45EC276Q58605269-A472F8C0-5CB2-4810-BAB4-1C74C16129F7Q59809814-F7A1023B-AF11-4521-8CE9-8AB28BA04E5BQ64965049-6B0F8A0F-8370-4580-920D-1EAE99AF7856Q80034371-B5539F83-3C9B-4046-A0F1-D78768E2A647Q83851839-BF4F19F6-38D4-4FEA-8CCE-332E9712ACA8
P50
description
researcher, ORCID id # 0000-0001-5303-2290
@en
wetenschapper
@nl
name
Geert Goderis
@ast
Geert Goderis
@en
Geert Goderis
@es
Geert Goderis
@nl
type
label
Geert Goderis
@ast
Geert Goderis
@en
Geert Goderis
@es
Geert Goderis
@nl
prefLabel
Geert Goderis
@ast
Geert Goderis
@en
Geert Goderis
@es
Geert Goderis
@nl
P106
P2456
P31
P496
0000-0001-5303-2290